{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:50:57Z","timestamp":1780415457990,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jaci.2019.10.033","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T19:40:42Z","timestamp":1573587642000},"page":"868-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Allergic disease, corticosteroid use, and risk of Hodgkin lymphoma: A\u00a0United Kingdom nationwide case-control study"],"prefix":"10.1016","volume":"145","author":[{"given":"Meena","family":"Rafiq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Warren-Gash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Denaxas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Gonzalez-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Lyratzopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.10.033_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mpo.1257","article-title":"Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials","volume":"38","author":"Bleyer","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaci.2019.10.033_bib2","author":"Alarcon"},{"key":"10.1016\/j.jaci.2019.10.033_bib3","first-page":"1324","article-title":"Characteristics of Hodgkin's lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003"},{"key":"10.1016\/j.jaci.2019.10.033_bib4","doi-asserted-by":"crossref","unstructured":"Henle W, Henle G. Seroepidemiology of the virus, In: The Epstein-Barr Virus. Berlin: Springer, 1979. p. 61-78.","DOI":"10.1007\/978-3-642-67236-1_4"},{"key":"10.1016\/j.jaci.2019.10.033_bib5","article-title":"IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Epstein-Barr virus and Kaposi's sarcoma, herpesvirus\/human herpesvirus","year":"1997","journal-title":"Lyon (France): International Agency for Research on Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2019.10.033_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.semcancer.2013.07.005","article-title":"Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas","volume":"23","author":"Dolcetti","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaci.2019.10.033_bib8","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.10.033_bib9","series-title":"World Health Organization classification of tumours","article-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.jaci.2019.10.033_bib10","article-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008","journal-title":"Lyon (France): International Agency for Research on Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib11","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2019.10.033_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1097-0142(19830115)51:2<245::AID-CNCR2820510213>3.0.CO;2-W","article-title":"Hodgkin's disease in renal transplant recipients","volume":"51","author":"Doyle","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3904\/kjim.2006.21.1.46","article-title":"Epstein-Barr virus-associated Hodgkin's disease following renal transplantation","volume":"21","author":"Choi","year":"2006","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jaci.2019.10.033_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0002-9343(89)80701-6","article-title":"Primary Hodgkin's lymphoma: an unusual cause of graft dysfunction after kidney transplantation","volume":"87","author":"Oldhafer","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2019.10.033_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaci.2019.10.033_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semdp.2012.08.005","article-title":"Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders","volume":"30","author":"Bagg","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.jaci.2019.10.033_bib17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/MIB.0b013e3182807618","article-title":"Do inflammatory bowel disease therapies cause cancer?","volume":"19","author":"Mason","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.10.033_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jnci\/djh135","article-title":"Familial clustering of Hodgkin lymphoma and multiple sclerosis","volume":"96","author":"Hjalgrim","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaci.2019.10.033_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/kel444","article-title":"Hodgkin's lymphoma in systemic lupus erythematosus","volume":"46","author":"Bernatsky","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2019.10.033_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008469-200002000-00008","article-title":"Medical history and\u00a0risk\u00a0of\u00a0Hodgkin's and non-Hodgkin's lymphomas","volume":"9","author":"Tavani","year":"2000","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jaci.2019.10.033_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaci.2019.10.033_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnci\/djr516","article-title":"Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups","volume":"104","author":"Urayama","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaci.2019.10.033_bib23","doi-asserted-by":"crossref","first-page":"e39986","DOI":"10.1371\/journal.pone.0039986","article-title":"HLA associations in classical Hodgkin lymphoma: EBV status matters","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.10.033_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2458-4-51","article-title":"Allergic conditions and risk of hematological malignancies in adults: a cohort study","volume":"4","author":"S\u00f6derberg","year":"2004","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jaci.2019.10.033_bib25","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","article-title":"Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden","volume":"42","author":"S\u00f6derberg","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib26","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/1097-0142(19931001)72:7<2148::AID-CNCR2820720714>3.0.CO;2-Q","article-title":"Antigenic stimulation and multiple myeloma. A\u00a0prospective study","volume":"72","author":"Bourguet","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism for childhood acute lymphoblastic leukaemia [published correction: Nat Rev Cancer 2018;18:526]","volume":"18","author":"Greaves","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.leukres.2014.08.004","article-title":"Allergy and risk of hematologic\u00a0malignancies: associations and mechanisms","volume":"38","author":"Musolino","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2019.10.033_bib29","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/bjc.2013.237","article-title":"Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia","volume":"108","author":"Nunez-Enriquez","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jech.54.6.431","article-title":"Haematopoietic cancer and medical history: a multicentre case control study","volume":"54","author":"Vineis","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jaci.2019.10.033_bib31","first-page":"261","article-title":"Risk patterns of Hodgkin's disease in Los Angeles vary by cell type","volume":"1","author":"Cozen","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaci.2019.10.033_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/aje\/kwv081","article-title":"Autoimmune and atopic disorders and risk of classical Hodgkin lymphoma","volume":"182","author":"Hollander","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaci.2019.10.033_bib33","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ijc.28785","article-title":"Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study","volume":"135","author":"Linabery","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib34","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ejca.2011.12.010","article-title":"Allergy-associated symptoms in relation to childhood non-Hodgkin\u2019s as contrasted to Hodgkin\u2019s lymphomas: a case\u2013control study in Greece and meta-analysis","volume":"48","author":"Dikalioti","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib35","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.leukres.2007.02.019","article-title":"Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph","volume":"31","author":"Becker","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2019.10.033_bib36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(97)07302-9","article-title":"Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.10.033_bib37","series-title":"Cancer today (powered by GLOBOCAN 2018) IARC CancerBase No.15","author":"Ferlay","year":"2018"},{"key":"10.1016\/j.jaci.2019.10.033_bib38","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2009.02.028","article-title":"Lymphoma among patients with atopic dermatitis and\/or treated with topical immunosuppressants in the United Kingdom","volume":"123","author":"Arellano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.10.033_bib39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5700622","article-title":"Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis","volume":"127","author":"Arellano","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.10.033_bib40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","article-title":"Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis","volume":"72","author":"Legendre","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.10.033_bib41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/ard.2005.036459","article-title":"Do steroids increase lymphoma risk? A\u00a0case\u2013control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.10.033_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000209289","article-title":"Topical treatments with pimecrolimus, tacrolimus and medium-to high-potency corticosteroids, and risk of lymphoma","volume":"219","author":"Schneeweiss","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2019.10.033_bib43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaci.2019.10.033_bib44","unstructured":"Availability of linked data - CPRD Linked Data. Available at: https:\/\/www.cprd.com\/linked-data. Accessed November 25, 2019."},{"key":"10.1016\/j.jaci.2019.10.033_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2019.10.033_bib47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/aje\/kwn217","article-title":"What do case-control studies estimate? Survey of methods and assumptions in published case-control research","volume":"168","author":"Knol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaci.2019.10.033_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pds.4145","article-title":"New use of prescription drugs prior to a cancer diagnosis","volume":"26","author":"Potteg\u00e5rd","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2019.10.033_bib49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/1097-0142(195709\/10)10:5<1045::AID-CNCR2820100527>3.0.CO;2-0","article-title":"Epidemiological evidence of the nature of Hodgkin's disease","volume":"10","author":"MacMahon","year":"1957","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2019.10.033_bib50","first-page":"1189","article-title":"Epidemiology of Hodgkin's disease","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2019.10.033_bib51","first-page":"B4485","article-title":"On the aetiology of Hodgkin lymphoma","volume":"59","author":"Hjalgrim","year":"2012","journal-title":"Dan Med J"},{"key":"10.1016\/j.jaci.2019.10.033_bib52","doi-asserted-by":"crossref","first-page":"e017474","DOI":"10.1136\/bmjopen-2017-017474","article-title":"Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)","volume":"7","author":"Nissen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaci.2019.10.033_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pds.3374","article-title":"Cancer recording and mortality in the General Practice Research Database and linked cancer registries","volume":"22","author":"Boggon","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2019.10.033_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1398-9995.2010.02458.x","article-title":"Role of PD-L1 and PD-L2 in allergic diseases and asthma","volume":"66","author":"Singh","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.10.033_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.10.033_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mi.2009.112","article-title":"PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions","volume":"3","author":"Akbari","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2019.10.033_bib57","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.172.4.2530","article-title":"B7-DC regulates asthmatic response by an IFN-\u03b3-dependent mechanism","volume":"172","author":"Matsumoto","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.10.033_bib58","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.173.2.1360","article-title":"Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody","volume":"173","author":"Radhakrishnan","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.10.033_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.10.033_bib60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.it.2008.12.004","article-title":"Linking allergy to autoimmune disease","volume":"30","author":"Valenta","year":"2009","journal-title":"Trend Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919314848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919314848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:23:37Z","timestamp":1758792217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919314848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0091674919314848"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.10.033","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic disease, corticosteroid use, and risk of Hodgkin lymphoma: A\u00a0United Kingdom nationwide case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}